image
CytomX Therapeutics, Inc. CTMX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.9605
0.541 %
$ 76.9 M
Market Cap
2.54
P/E
BALANCE SHEET
121 M ASSETS
-40.27%
Growth Rates
1Year -40.27%
3Years -29.18%
5Years -18.79%
7Years -15.68%
10Years 5.13%
121 M LIABILITIES
-51.46%
Growth Rates
1Year -51.46%
3Years -21.49%
5Years -16.05%
7Years -13.27%
10Years -2.23%
-456 K EQUITY
99.04%
Growth Rates
1Year 99.04%
3Years -0.17%
5Years -0.18%
7Years -0.09%
10Years 40.24%
BALANCE SHEET DECOMPOSITION
Balance Sheet CytomX Therapeutics, Inc.
image
Current Assets 107 M
Cash & Short-Term Investments 101 M
Receivables 3.1 M
Other Current Assets 3.58 M
Non-Current Assets 13.2 M
Long-Term Investments 0
PP&E 10.6 M
Other Non-Current Assets 2.62 M
83.48 %2.97 %8.80 %Total Assets$120.5m
Current Liabilities 85.8 M
Accounts Payable 1.09 M
Short-Term Debt 5.14 M
Other Current Liabilities 79.5 M
Non-Current Liabilities 35.2 M
Long-Term Debt 0
Other Non-Current Liabilities 35.2 M
4.25 %65.74 %29.11 %Total Liabilities$121.0m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
ASSETS
Cash & Cash Equivalents 38.1 17.2 193.7 205.5 191.9 188.4 247.6 177.5 104.6 59.8 64.4 8.7
Short Term Investments 62.6 157.3 0 99.7 124.3 107.7 188.6 196.6 77.3 126.9 0 0
Receivables 3.1 3.4 36.0 0.8 0.8 13 K 97 K 10.1 2.3 0.7 1.9 0.2
Inventory 0 0 0 1 1 1 0 1 1 1 100 K 100 K
Other Current Assets 3.6 5.0 7.5 8.6 14.2 14.4 18.5 8.7 3.9 4.6 0.6 0.3
Total Current Assets 107.3 182.9 237.1 310.3 324.0 303.3 445.5 388.6 188.1 189.8 66.9 9.3
PP&E 10.6 16.2 21.0 25.3 29.4 32.8 6.9 4.2 4.4 3.5 3.0 2.1
Intangible Assets 0.6 0.7 0.9 1.0 1.2 1.3 1.5 1.6 1.8 1.8 1.8 1.8
Goodwill 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9
Long Term Investments 0 0 0.9 0.9 0.9 0.9 0.9 0.9 0.9 1.0 0 0
Other Long Term Assets 1.1 1.0 (3.6) (3.7) (3.4) 2.9 0.2 1.0 2.7 (0.1) 0.5 0.1
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 120.5 201.8 260.9 339.4 358.7 341.3 457.1 397.6 199.1 197.2 73.1 14.2
LIABILITIES
Accounts Payable 1.1 1.5 2.8 2.8 3.0 4.2 5.1 4.2 6.6 4.7 1.9 0.9
Short Term Debt 5.1 4.6 4.1 3.6 3.2 2.8 0 0 0 0 1.4 1.3
Other Current Liabilities 12.3 17.6 24.4 30.6 19.9 27.2 26.7 16.4 8.8 4.9 1.7 1.1
Total Current Liabilities 85.8 155.9 152.6 106.3 100.9 85.6 97.9 61.1 35.8 15.7 11.2 4.2
Long Term Debt 0 9.4 27.9 36.1 43.4 49.7 0 0 0 0 1.6 2.9
Deferred Tax Income 0 0 3.6 4.6 5.5 0 1.1 0.4 0.5 0.5 0.5 0.5
Other Liabilities 35.2 3.9 (14.0) 100.2 (21.7) (24.0) 3.0 1.9 0.6 0.2 77.5 46.2
Total Liabilities 121.0 249.2 346.6 250.0 308.9 290.2 326.2 327.7 120.6 71.1 151.6 58.5
EQUITY
Common Stock 1 K 1 K 1 K 1 K 1 K 1 K 1 K 1 K 1 K 1 K 1 K 1 K
Retained Earnings (691.6) (723.4) (722.9) (533.7) (450.1) (417.2) (315.0) (219.5) (176.4) (117.5) (78.1) (43.9)
Other Accumulative Comprehensive Income/Loss 27 K 95 K 10 K (0.2) 47 K 57 K 93 K 94 K 27 K 76 K (0.4) (0.4)
Total Equity (0.5) (47.4) (85.8) 89.4 49.8 51.1 130.9 69.9 78.5 126.1 (78.5) (44.3)
Total Liabilities and Equity 120.5 201.8 260.9 339.4 358.7 341.3 457.1 397.6 199.1 197.2 73.1 14.2
SHARES OUTSTANDING
Common Shares Outstanding 84.4 73.8 65.7 64.1 46.1 45.3 41.7 37.2 36.2 8.6 34.9 34.9